Authors:
Hirayama, F
Honjo, M
Arima, H
Okimoto, K
Uekama, K
Citation: F. Hirayama et al., X-ray crystallographic characterization of nilvadipine monohydrate and itsphase transition behavior, EUR J PH SC, 11(1), 2000, pp. 81-88
Authors:
Okimoto, K
Kouchi, M
Kikawa, E
Toyosawa, K
Koujitani, T
Tanaka, K
Matsuoka, N
Sakurai, J
Hino, O
Citation: K. Okimoto et al., A novel "Nihon" rat model of a Mendelian dominantly inherited renal cell carcinoma, JPN J CANC, 91(11), 2000, pp. 1096-1099
Citation: K. Murai et al., Study on masticatory movement and its ability: Efficacy of a test capsule in the evaluation of masticatory movement, J ORAL REH, 27(1), 2000, pp. 64-69
Authors:
Okimoto, K
Ohike, A
Ibuki, R
Aoki, O
Ohnishi, N
Irie, T
Uekama, K
Rajewski, RA
Stella, VJ
Citation: K. Okimoto et al., Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)(7m)-beta-CD, PHARM RES, 16(4), 1999, pp. 549-554
Citation: Hh. Moroi et al., The effect of an oral prosthesis on the quality of life for head and neck cancer patients, J ORAL REH, 26(4), 1999, pp. 265-273
Authors:
Okimoto, K
Ohike, A
Ibuki, R
Aoki, O
Ohnishi, N
Rajewski, RA
Stella, VJ
Irie, T
Uekama, K
Citation: K. Okimoto et al., Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent, J CONTR REL, 60(2-3), 1999, pp. 311-319
Citation: K. Okimoto et al., Release of testosterone from an osmotic pump tablet utilizing (SBE)(7m)-beta-cyclodextrin as both a solubilizing and an osmotic pump agent, J CONTR REL, 58(1), 1999, pp. 29-38